|
⚲
|
| Keyboard |
| Femasys Inc | |
|---|---|
| Ticker | FEMY |
| CIK # | 0001339005 |
| CUSIP | 31447E105 |
| Sector | Life Sciences - Surgical & Medical Instruments & Apparatus |
| Address | 3950 Johns Creek Court Suite 100, Suwanee, GA 30024 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Femasys Inc | 2025-11-14 | 8.0 M | Exemption: 506(b) · Remaining: $3,975,000 · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001339005] | 10-K | |
| [0001339005] | 10-Q | |
| [0001339005] | 3 | |
| [0001339005] | 4 | |
| [0001339005] | 8-K | |
| [0001339005] | D | |
| [0001339005] | SC 13D | |
| [0001339005] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Pharmacyte Biotech Inc | Femasys Inc | [2026-03-18] | 0.0 |
| Chernett Jorey | Femasys Inc | [2025-02-26] | 0.0 |
| Dauntless Investment Group LLC | Femasys Inc | [2025-02-26] | 0.0 |
| Pharmacyte Biotech Inc | Femasys Inc | [2023-11-22] | 37.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Elefant Dov
Series D-1 Warrants · derivative
|
2026-03-19 | Grant | 34,122 | ||
|
Lee-Sepsick Kathy
Series D-1 Warrants · derivative
|
2026-03-19 | Grant | 68,244 | ||
|
Larsen Charles
Series D-1 Warrants · derivative
|
2026-03-19 | Grant | 34,122 | ||
|
Eichenbaum Kenneth D
Series D-1 Warrants · derivative
|
2026-03-19 | Grant | 102,366 | ||
|
Eichenbaum Kenneth D
Stock Option (Right to Buy) · derivative
|
2026-03-18 | Grant | 35,200 | $0.00 | |
|
Lee-Sepsick Kathy
Restricted Stock Units · derivative
|
2026-02-19 | Grant | 282,000 | $0.00 | |
|
Lee-Sepsick Kathy
Restricted Stock Units · derivative
|
2026-02-19 | Grant | 447,000 | $0.00 | |
|
Elefant Dov
Restricted Stock Units · derivative
|
2026-02-19 | Grant | 169,000 | $0.00 | |
|
Elefant Dov
Restricted Stock Units · derivative
|
2026-02-19 | Grant | 173,000 | $0.00 | |
|
Sipos Jeremy Alexander
Restricted Stock Units · derivative
|
2026-02-02 | Grant | 80,000 | $0.00 | |
|
Lee-Sepsick Kathy
Series A-1 Warrants · derivative
|
2025-11-07 | Discretionary | 68,244 | ||
|
Lee-Sepsick Kathy
Series C-1 Warrants · derivative
|
2025-11-07 | Discretionary | |||
|
Lee-Sepsick Kathy
Senior Secured Convertible Notes · derivative
|
2025-11-07 | Discretionary | 68,244 | ||
|
Lee-Sepsick Kathy
Series B-1 Warrants · derivative
|
2025-11-07 | Discretionary | 68,244 | ||
|
Larsen Charles
Senior Secured Convertible Notes · derivative
|
2025-11-07 | Discretionary | 34,122 | ||
|
Larsen Charles
Series A-1 Warrants · derivative
|
2025-11-07 | Discretionary | 34,122 | ||
|
Larsen Charles
Series B-1 Warrants · derivative
|
2025-11-07 | Discretionary | 34,122 | ||
|
Larsen Charles
Series C-1 Warrants · derivative
|
2025-11-07 | Discretionary | |||
|
Elefant Dov
Senior Secured Convertible Notes · derivative
|
2025-11-07 | Discretionary | 34,122 | ||
|
Elefant Dov
Series A-1 Warrants · derivative
|
2025-11-07 | Discretionary | 34,122 | ||
| showing 20 of 105 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 36 | 9,472,339 |
| 2025-12-31 | 38 | 9,459,527 |
| 2025-09-30 | 32 | 3,755,840 |
| 2025-06-30 | 35 | 5,196,454 |
| 2025-03-31 | 31 | 3,904,241 |
| 2024-12-31 | 30 | 2,385,879 |
| 2024-09-30 | 28 | 1,672,303 |
| 2024-06-30 | 29 | 1,639,679 |
| 2024-03-31 | 24 | 1,524,858 |
| 2023-12-31 | 25 | 1,478,274 |
| 2023-09-30 | 29 | 1,688,527 |
| 2023-06-30 | 23 | 1,291,154 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| IFP Advisors LLC | [2026-06-30] | SOLE | 1,000 | 1,000 |
| CX Institutional | [2026-06-30] | SOLE | 0 | 750 | Prev | Page 1 | Next |